Detalhe da pesquisa
1.
The effect of antimalarials on the safety and persistence of treatment with biologic agents or Janus kinase inhibitors in rheumatoid arthritis.
Rheumatology (Oxford);
63(2): 456-465, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37216912
2.
Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.
Clin Exp Rheumatol;
40(7): 1258-1266, 2022 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34251312
3.
Safety of the Methotrexate-leflunomide Combination in Rheumatoid Arthritis: Results of a Multicentric, Registry-based, Cohort Study (BiobadaBrasil).
J Rheumatol;
48(10): 1519-1527, 2021 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33934077
4.
Safety of the Methotrexate-leflunomide Combination in Rheumatoid Arthritis: Results of a Multicentric, Registry-based, Cohort Study (BiobadaBrasil).
J Rheumatol;
49(1): 122, 2022 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34974425